A judge has thrown out a notice to produce issued by an Australian company being targeted by UK genomic sequencing company Oxford Nanopore Technologies, calling its bid for board minutes and other documents a “fishing expedition”.
Moderna has failed in its bid to secure an mRNA vaccine patent, but an IP Australia delegate gave the US biotech another shot at its application.
Apple has defeated a claim by an Australian non-practicing entity that its patents for a remote entry system were infringed by the tech company’s Touch ID and Face ID technology.
The High Court has agreed to hear an Australian fashion designer’s appeal in a long-running trade mark dispute with pop star Katy Perry.
A group of Australia’s leading beef and dairy companies has failed to strike-out a suit alleging their genetic testing system for cattle infringes the patent of a US genomics company, with a judge rejecting objections to the phrase ‘further or in the alternative’.
The High Court won’t hear Bayer’s appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company’s claim the decision has “profound” consequences for drug R&D.
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.
The makers of Grand Theft Auto have largely succeeded in a copyright case against the developer behind the “Infamous Mod” — a hack that alters the capabilities of players in the online version of the top-selling game.
The High Court has rejected Aristocrat’s request that it rule again on the patentability of its popular Lightning Link game, after a differently comprised court was split on when computer-implemented inventions can be patented.
Radio manufacturer Hytera wants the High Court to hear its appeal of a finding that it misappropriated Motorola’s source code in a case of “substantial industrial theft”.